Latest offering from the world leader in automated peritoneal dialysis (APD) technology
Approved for adult and pediatric populations
Characteristics Share source, the only two-way remote patient management platform available in Canada for patients with renal impairment
Large randomized study shows nearly twice the survival rates in patients using Share source remote patient management
MISSISSAUGA, ON, December 1, 2021 / CNW / – Baxter Canada, an innovator in kidney care, today announced Health Canada’s license for the Homechoice Claria APD System with the Sharesource digital health platform. Homechoice Claria is indicated for adult and pediatric patients on peritoneal dialysis (PD) and combines a simple user interface with the benefits of Sharesource, the only two-way remote patient management platform in Canada.
“The approval of House choice Claria with Share source dramatically accelerates our mission to improve the quality of life of Canadian patients with Parkinson’s disease, âsaid Neil Da Silva, business unit director, nephrology. âThrough digital connectivity, we are delighted to offer another therapy management tool that allows patients to feel safe and comfortable at home with the confidence of always being connected to their clinician. confidence. “
New data presented during the American Society of Nephrology’s annual Kidney Week 2021 showed that patients can experience an almost twice the survival rate and a prolonged time to an adverse event and hospitalization when the Share source Remote Patient Management Digital Health Platform is used to help manage ODA at home.1
Share source Remote patient management allows healthcare professionals to monitor their patients’ home dialysis treatments and then adjust treatment remotely without patients having to visit the clinic unexpectedly. Share source is the most widely implemented home dialysis digital health platform. It is used to treat almost 50% of all patients on Baxter APD systems around the world. The digital health platform is available in over 70 countries and has managed over 32 million treatments to date.
At the intersection of simplicity and connectivity, more information is available at baxter.ca/healthcare-professionals/renal-care/homechoice-claria-enabled-sharesource.
On Baxter Canada
Every day, millions of patients and caregivers rely on Baxter leading portfolio of intensive care, nutrition, nephrology, hospital and surgical products. In Canada, we operate at the critical intersection where innovations that save and sustain lives meet healthcare providers who have succeeded for 84 years. With products, technologies and therapies available in over 100 countries, Baxter employees around the world are now building on the company’s rich legacy of medical breakthroughs to advance the next generation of transformative healthcare innovations. Baxter Canada and its more than 1,200 employees are located primarily in Ontario at the head office, CIVA mixing and technical service centers in Mississauga, and in Alliston – where Baxter operates the only large-scale manufacturing facility in Canada producing life-sustaining intravenous and dialysis solutions. To learn more, visit www.baxter.ca and follow Baxter Canada on Linkedin.
For safe and proper use of this device, refer to the complete user manual.
The House choice Claria The APD System is intended for the automatic control of the exchange of dialysis solutions in the treatment of pediatric and adult renal patients undergoing peritoneal dialysis in the home care environment, including comparable use in professional healthcare facilities.
Baxter, House choice Claria, and Share source are registered trademarks of Baxter International Inc.
1 Paniagua R, et al. Summary presented at ASN Kidney Week 2021. Virtual. 2021. [PO0965]
SOURCE Baxter Corporation
View original content to download multimedia: http://www.newswire.ca/en/releases/archive/December2021/01/c8644.html